Wellington Global Health Care Equity Fund USD D Ac
Equity fund
1 year
USA
Largest region
Medium
Risk
Annual costs
Morningstar
Partial
Sustainability
Development
Last 5 years
( ann.)
Details
- Porteføljen søker langsiktig avkastning. Porteføljen investerer primært, enten direkte eller indirekte via derivater, i aksjer og andre verdipapirer med aksjekjennetegn (som preferanseaksjer, konvertible verdipapirer eller innskuddsbevis) utstedt av selskaper aktive innen helseomsorgsområdet verden over med markedskapitalisering normalt over USD 1 milliard. Porteføljen følger en nedenfra-og-opp aksjevalgsholdning. Mens det ikke er noen restriksjoner når det gjelder porteføljens evne til å bruke derivater for investeringsformål (som å få eksponering mot et verdipapir), bruker porteføljen primært derivater for å sikre (redusere) risikoen.
Investment horizon
- Wellington Global Health Care Equity Fund USD D Ac is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- NAV/Price
17 Dec 2025
- Margin rate
- Start date29 Sept 2006
- ISINIE00B00LSD17
Risk
- Medium (4 of 7)
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityPartial
Annual cost
- Ongoing costs
Includes management fees of 1,25 %
- Platform fee
- Kickback fee
- Annual running costs
Other costs
- Performance-based fee
- Transaction costs
Costs for any currency exchanges are not included.
Allocation
- Stocks 99%Interest 1%
Portfolio
Shows the fund's largest investments.
- Eli Lilly and Co9.6%
- AstraZeneca PLC4.8%
- UnitedHealth Group Inc3.9%
- Merck & Co Inc3.7%
- Intuitive Surgical Inc2.9%
- Edwards Lifesciences Corp2.7%
- AbbVie Inc2.7%
- Vertex Pharmaceuticals Inc2.7%
- GSK PLC2.6%
- Johnson & Johnson2.5%